TP53 and cancer: Cancer virotherapy is a strategy in which viruses are modified to preferentially replicate in tumour cells and lead to cell death, through targeted alterations in the cancer cells, such as p53 mutation, viral deletion, tissue-specific transcriptional control, or tumour-specific receptors.